Status: Not yet recruiting
Adebrelimab Combined With AG Regimen in Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer
This study aims to evaluate the efficacy and safety of adebrelimab combined with the AG regimen in patients with unresectable locally advanced or metastatic pancreatic cancer who have received at least one prior line of systemic therapy but have not undergone gemcitabine-based treatment.
Participants needed: 46
Trial details
Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Jin XuUpdated: Apr 8, 2025Locations: 1
Eligibility criteria
Sign informed consent； [+11]
The subject has any known active autoimmune disease; [+11]